Percheron Therapeutics ( (AU:PER) ) has shared an update.
Percheron Therapeutics Limited has announced a change in the director’s interest, with Director James Garner acquiring 7.5 million fully paid ordinary shares, increasing his total holding to 50 million shares. The acquisition was made through on-market purchases, reflecting a strategic move to strengthen his stake in the company, potentially signaling confidence in the company’s future prospects.
More about Percheron Therapeutics
Technical Sentiment Signal: Sell
Current Market Cap: $7.54M
See more insights into PER stock on TipRanks’ Stock Analysis page.